New Jersey is currently home to 1652 active clinical trials, seeking participants for engagement in research studies. These trials take place at a variety of cities in the state, including New Brunswick, Hackensack, Newark and Morristown. Whether you're a healthy volunteer interested in paid medical research or someone seeking trials related to a specific condition, the state offers a diverse array of opportunities in your vicinity.
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
NCT05865184
Recruiting
Sensorum Health (Sensorum) is conducting a pilot study to determine if Sensorum's proprietary passive sensor network can be used to identify signals of early health decompensation in subjects prior to a hospitalization for chronic disease exacerbation or other ambulatory care sensitive conditions. Successful early detection would provide a window of opportunity to intervene outside of the acute setting in future interventional studies.
Gender:
ALL
Ages:
65 years and above
Trial Updated:
05/09/2023
Locations: Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, New Jersey
Conditions: COPD, Chronic Obstructive Pulmonary Disease, COPD Exacerbation, CHF, Congestive Heart Failure
Register for Updates
Spinal Cord Transcutaneous Stimulation Effect on Blood Pressure in Acute Spinal Cord Injury (SCI)
NCT05731986
Recruiting
The goal of this clinical trial is to evaluate the effect of transcutaneous spinal cord stimulation on blood pressure in individuals with an acute spinal cord injury (within 30 days of injury). Blood pressure instability, specifically orthostatic hypotension (a drop in blood pressure when moving lying flat on your back to an upright position), appears early after the injury and often significantly interferes with participation in the critical rehabilitation time period. The main questions it ai... Read More
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
05/08/2023
Locations: Kessler Foundation, West Orange, New Jersey
Conditions: Spinal Cord Injuries, Spinal Cord Diseases, Trauma, Nervous System, Nervous System Diseases, Central Nervous System Diseases, Hypotension, Orthostatic Hypotension, Cardiovascular Diseases, Acute Spinal Cord Injury, Blood Pressure
Register for Updates
The Effect of Transcutaneous Stimulation on Blood Pressure in Spinal Cord Injury (SCI)
NCT05725499
Recruiting
This project will investigate the effect of spinal cord transcutaneous stimulation on blood pressure in individuals with a chronic spinal cord injury who experience blood pressure instability, specifically, orthostatic hypotension (a drop in blood pressure when moving from lying flat on your back to an upright position). The main questions it aims to answer are: 1. What are the various spinal sites and stimulation parameters that normalize and stabilize blood pressure during an orthostatic pro... Read More
Gender:
ALL
Ages:
Between 18 years and 75 years
Trial Updated:
05/08/2023
Locations: Kessler Foundation, West Orange, New Jersey
Conditions: Spinal Cord Injuries, Hypotension, Orthostatic Hypotension, Spinal Cord Diseases, Cardiovascular Diseases, Trauma, Nervous System, Central Nervous System Diseases, Nervous System Diseases, Blood Pressure
Register for Updates
PyloPlus Urea Breath Test System Post Therapy Efficacy Confirmation Study
NCT05681689
Recruiting
This is a multi-center, non-randomized, open label study. Subjects will be enrolled if they are deemed eligible given the inclusion criteria. Subjects who meet all inclusion criteria and none of the exclusion criteria will be entered into the study. Subjects will be exposed to non-radioactive 13C-Urea with citric acid, and may submit a stool sample or undergo endoscopy for Rapid Urease Test and Histology samples. Center(s) will house a PyloPlus UBT Analyzer to document results. PyloPlus Analyze... Read More
Gender:
ALL
Ages:
18 years and above
Trial Updated:
05/03/2023
Locations: Hudson County Clinical Trials Research Center, Union City, New Jersey
Conditions: Helicobacter Pylori Infection, Post-Treatment, Efficacy
Register for Updates
Combining Wearable Robotic Orthosis With Visual and Haptic Feedback to Enhance the Recovery of Upper Extremity Motor Function and ADL in Persons With Acute SCI
NCT05386537
Recruiting
This randomized clinical trial (RCT) is evaluating the usefulness of combining MyoMo robotic orthosis with visual and haptic feedback in ameliorating wrist/hand/UE movement capability, and increasing ADL and quality of life in people with acute SCI.
Gender:
ALL
Ages:
Between 18 years and 80 years
Trial Updated:
05/03/2023
Locations: Kessler Foundation, West Orange, New Jersey
Conditions: SCI - Spinal Cord Injury
Register for Updates
Determine Safety & Recommended Phase 2 Dosing of Zeaxanthin Alone or in Combination w/Pembrolizumab in Patients With Metastatic Cancer
NCT05232409
Recruiting
The purpose of the research is to determine the highest dose of an oral compound called zeaxanthin that can be safely taken each day in patients with advanced cancer, the toxicity profile of zeaxanthin, and the dose of zeaxanthin to use in future cancer clinical trials.
Gender:
ALL
Ages:
Between 18 years and 99 years
Trial Updated:
04/19/2023
Locations: The Valley Hospital-Luckow Pavilion, Paramus, New Jersey
Conditions: Cancer Metastatic, Metastatic Solid Tumor
Register for Updates
Safety of Cyberknife in Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma
NCT04998552
Recruiting
The hypothesize that SBRT will limit or reverse tumor growth and thereby convert the borderline resectable disease or locally advanced disease in to a resectable tumor. Furthermore, we want to assess whether SBRT leads to an improved quality of life compared to IMRT.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/30/2023
Locations: Capital Health Medical Center-Hopewell, Pennington, New Jersey
Conditions: Pancreas Adenocarcinoma
Register for Updates
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
NCT02205762
Recruiting
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age \< 18 years).
Gender:
ALL
Ages:
18 years and below
Trial Updated:
03/21/2023
Locations: Hackensack University Medical Center, Hackensack, New Jersey
Conditions: Langerhans Cell Histiocytosis
Register for Updates
Follow-up With Preimplantation Genetic Testing Patients
NCT04477863
Recruiting
The main purpose of this study is to perform longitudinal evaluations of clinical outcomes and personal perspectives following utilization of preimplantation genetic testing (PGT). Patients indicating willingness to participate in research during informed consent to perform PGT will be eligible for inclusion. A licensed genetic counselor will conduct a recorded interview.
Gender:
ALL
Ages:
All
Trial Updated:
02/21/2023
Locations: Genomic Prediction Clinical Laboratory, North Brunswick, New Jersey
Conditions: Infertility, Genetic Disease, IVF
Register for Updates
Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy
NCT01696721
Recruiting
In previous studies, Proton Beam Radiation Therapy (PBRT) has been found to show better results in treating patients with cancer, both because there is better control of where in the body the radiation is directed and because it is associated with less severe long term side effects. However, there is limited published data demonstrating these results. The goal of the Proton and Photon Consortium Registry (PPCR) is to enroll children treated with radiation in order to describe the population that... Read More
Gender:
ALL
Ages:
21 years and below
Trial Updated:
01/05/2023
Locations: ProCure Proton Therapy Center- New Jersey, Somerset, New Jersey
Conditions: Pediatric Patients Treated With Radiation Therapy
Register for Updates
Accelerated Corneal Collagen Crosslinking for Keratoconus and Ectasia Using Pulse or Continuous UV-A Light
NCT05027295
Recruiting
Corneal collagen crosslinking has been demonstrated as an effective method of reducing progression of both keratoconus and post-refractive corneal ectasia, as well as decreasing the steepness of the cornea in these pathologies. Performing an accelerated CXL procedure with pulsed UVA light may increase the oxygenation of the cornea, which may improve the crosslinking efficacy.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
12/30/2022
Locations: Cornea and Laser Eye Institute, Hersh Vision Group, Teaneck, New Jersey
Conditions: Keratoconus, Corneal Ectasia
Register for Updates
Transepithelial (Epi-on) Corneal Collagen Crosslinking to Treat Keratoconus and Corneal Ectasia
NCT04905108
Recruiting
Corneal collagen crosslinking (CXL) has been demonstrated as an effective method of reducing progression of both keratoconus and corneal ectasia after surgery, as well as possibly decreasing the steepness of the cornea in these pathologies. Transepithelial crosslinking in which the epithelium is not removed has been proposed to offer a number of advantages over traditional crosslinking including an increased safety profile by reducing the risk for infection and scarring, faster visual recovery a... Read More
Gender:
ALL
Ages:
12 years and above
Trial Updated:
12/30/2022
Locations: Cornea and Laser Eye Institute, Hersh Vision Group, Teaneck, New Jersey
Conditions: Keratoconus, Corneal Ectasia
Register for Updates